Reported about 5 hours ago
Alto Pharmacy, a San Francisco-based digital pharmaceutical startup, has raised $40 million through a convertible note, with participation from its existing investor, SoftBank Group. This new funding comes as Alto's valuation has dropped significantly from $1.8 billion during the pandemic to $786 million in its most recent funding round.
Source: YAHOO